Aevi Genomic Medicine, LLC
Aevi Genomic Medicine, LLC, a pioneering entity in the field of genomic medicine, is headquartered in the United States. Founded in 2013, the company has established itself as a leader in developing innovative therapies for rare genetic disorders, particularly focusing on paediatric populations. With a commitment to advancing precision medicine, Aevi Genomic Medicine offers unique solutions that leverage genomic insights to tailor treatments for individual patients. Their proprietary platform integrates advanced genomic technologies, setting them apart in the competitive landscape of biotechnology. Recognised for their significant contributions to the industry, Aevi has achieved notable milestones, including successful clinical trials that underscore their position as a key player in the genomic medicine sector. As they continue to expand their operational reach, Aevi remains dedicated to transforming the lives of patients through cutting-edge genomic therapies.
DitchCarbon Score
How does Aevi Genomic Medicine, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aevi Genomic Medicine, LLC's score of 18 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aevi Genomic Medicine, LLC's reported carbon emissions
Aevi Genomic Medicine, LLC, headquartered in the US, currently does not have any publicly available carbon emissions data or specific climate commitments. As such, there are no reported figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions. Additionally, the company has not outlined any reduction targets or initiatives aimed at mitigating climate impact. In the absence of specific emissions data or commitments, it is unclear how Aevi Genomic Medicine is addressing climate change within its operations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aevi Genomic Medicine, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
